The wearing-off phenomenon and the use of questionnaires to facilitate its recognition in Parkinson’s disease

被引:0
|
作者
Mark Stacy
机构
[1] Duke University Medical School,Division of Neurology
来源
关键词
Parkinson’s disease; Levodopa; Wearing-off; Questionnaire;
D O I
暂无
中图分类号
学科分类号
摘要
Long-term treatment of Parkinson’s disease (PD) with dopaminergic therapy is associated with a re-emergence of PD symptoms, referred to as wearing-off. Signs of wearing-off encompass motor symptoms, such as slowness of movement and stiffness, and non-motor symptoms, including anxiety and fatigue. Both motor and non-motor symptoms impact significantly on the function and quality of life of PD patients. Early detection and management of wearing-off has been shown to improve patient symptoms; however, identification of wearing-off, particularly the non-motor symptoms, is hampered by a lack of patient education, awareness, patient–physician communication, and limited time for evaluation. Several questionnaires have been developed to aid the detection of wearing-off. This review investigates the development and use of the Wearing-Off Questionnaires (WOQ-32, WOQ-19, and WOQ-9), as well as their sensitivity and specificity in identifying wearing-off. The manuscript also provides an overview of the motor and non-motor signs of wearing-off and highlights the available treatment strategies for managing this potentially debilitating phenomenon.
引用
收藏
页码:837 / 846
页数:9
相关论文
共 50 条
  • [31] Efficacy and tolerability of Stalevo® in patients with Parkinson's disease experiencing wearing-off
    Jost, WH
    Zeiler, B
    Nüdling, S
    Elsner, A
    Enk, C
    Roscher, T
    [J]. AKTUELLE NEUROLOGIE, 2005, 32 : S318 - S325
  • [32] Wearing-off Identification in Parkinson's Disease: The shapd-woq Study
    Wan, Ying
    Yuan, Canxing
    Hou, Xiaojun
    Chen, Wei
    Wang, ChunYan
    Gao, Shan
    Wang, Yuhui
    Jin, Lingjing
    Liu, Zhenguo
    [J]. FRONTIERS IN NEUROLOGY, 2020, 11
  • [33] A pilot program to evaluate a wearing-off questionnaire in patients with Parkinson's disease
    Panisset, M.
    Jog, M.
    Suchowersky, O.
    Miyasaki, J.
    Rehel, B.
    Schecter, R.
    [J]. MOVEMENT DISORDERS, 2006, 21 : S506 - S507
  • [34] Difference in perception of the wearing-off between patients and physicians in Parkinson's disease
    Tsuboi, Y.
    Nakagawa, R.
    Ishido, M.
    Yoshinaga, Y.
    Hashimoto, T.
    Mishima, T.
    Fujioka, S.
    [J]. MOVEMENT DISORDERS, 2019, 34 : S257 - S257
  • [35] Levodopa-related wearing-off in Parkinson's disease: identification and management
    Pahwa, Rajesh
    Lyons, Kelly E.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (04) : 841 - 849
  • [36] The availability of LSVT-BIG for Parkinson's disease patients with wearing-off
    Tomiyama, Masahiko
    Nunomura, Jinichi
    Sasaki, Megumi
    Ueno, Tatsuya
    Haga, Rie
    Funamizu, Yukihisa
    Kon, Tomoya
    Nishijima, Haruo
    Arai, Akira
    Suzuki, Chieko
    [J]. MOVEMENT DISORDERS, 2014, 29 : S34 - S35
  • [37] The patient card questionnaire to identify wearing-off in Parkinson disease
    Martinez-Martin, Pablo
    Tolosa, Eduardo
    Hernandez, Basilio
    Badia, Xavier
    [J]. CLINICAL NEUROPHARMACOLOGY, 2007, 30 (05) : 266 - 275
  • [38] Frequency and phenomenology of motor and non-motor features of wearing-off phenomenon in Brazilian Parkinson's disease patients
    Cardoso, F.
    Cesar, B. P.
    Teixeira, A. L., Jr.
    Camargos, S. T.
    Maia, D. P.
    Cunningham, M. C.
    [J]. MOVEMENT DISORDERS, 2007, 22 : S195 - S195
  • [39] The Efficacy of Istradefylline for Treating Mild Wearing-Off in Parkinson Disease
    Yabe, Ichiro
    Kitagawa, Mayumi
    Takahashi, Ikuko
    Matsushima, Masaaki
    Sasaki, Hidenao
    [J]. CLINICAL NEUROPHARMACOLOGY, 2017, 40 (06) : 261 - 263
  • [40] Clinical problems after long-term use of non-ergotamine dopamine agonists for wearing-off phenomenon in Parkinson's disease
    Shiraishi, M.
    Sasaki, N.
    Maki, F.
    Yanagisawa, T.
    Akiyama, H.
    Hirayama, T.
    Hasegawa, Y.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 669 - 669